Yale University: Alzheimer Disease trials
The registry lists 11 Alzheimer Disease studies with Yale University as lead sponsor. 3 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 2Phase 2 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Music for Pain and DementiaRecruitingNCT07602283Not applicable
- Exploring the Utility of [18F]3F4AP for Demyelination ImagingRecruitingNCT06999434Phase 1
- Evaluation of a Mobile App Program for Coping With CancerRecruitingNCT06923501Not applicable
- Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923CompletedNCT04805983Phase 1Results posted
- Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's DiseaseCompletedNCT04057807Early Phase 1Results posted
- A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's DiseaseCompletedNCT02167256Phase 2Results posted
- Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their CaregiversCompletedNCT06940687Not applicable
- Electronic Consultation for AD/ADRD Residents Experiencing Infectious DiseasesWithdrawnNCT04812769Not applicable
- Families Coping Together With Alzheimer's DiseaseCompletedNCT04642885
- Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver DyadsWithdrawnNCT02506374
- Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer'sCompletedNCT02502045Not applicable